SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-17-044014
Filing Date
2017-08-18
Accepted
2017-08-18 07:17:54
Documents
1
Period of Report
2017-07-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v473644_3.html 3  
1 OWNERSHIP DOCUMENT v473644_3.xml 3 3776
  Complete submission text file 0001144204-17-044014.txt   5364
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Issuer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9TH FLOOR, NO.2 EAST FUXING ROAD SHANGHAI F4 200010
Business Address 9TH FLOOR, NO.2 EAST FUXING ROAD SHANGHAI F4 200010 86 21 23138051
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Reporting) CIK: 0001615258 (see all company filings)

State of Incorp.: F4 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36577 | Film No.: 171040096